Insider · CIK 0001519419
Kevin Lobo
Files at PH (Parker-Hannifin Corp), SYK (STRYKER CORP). First filing Nov 8, 2024, latest Nov 8, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SYK: STRYKER CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 23, 2024 | PH Parker-Hannifin Corp | AGrant or award Restricted Stock Units | +299 | $0.00 | $0 | 11,077 | Apr 25, 2025 |
| Nov 13, 2024 | PH Parker-Hannifin Corp | GGift Common Stock | -3,465 | $0.00 | $0 | 7,612 | Nov 15, 2024 |
| Nov 7, 2024 | SYK STRYKER CORP | MOption exercise Common Stock | +156,890 | $93.06 | $15M | 256,917 | Nov 8, 2024 |
| Nov 7, 2024 | SYK STRYKER CORP | FTax withholding Common Stock | -99,577 | $369.02 | $37M | 157,340 | Nov 8, 2024 |
| Nov 7, 2024 | SYK STRYKER CORP | SOpen-market sale Common Stock | -18,269 | $367.95 | $6.7M | 139,071 | Nov 8, 2024 |
| Nov 7, 2024 | SYK STRYKER CORP | SOpen-market sale Common Stock | -23,178 | $368.58 | $8.5M | 115,893 | Nov 8, 2024 |
| Nov 7, 2024 | SYK STRYKER CORP | SOpen-market sale Common Stock | -15,866 | $369.75 | $5.9M | 100,027 | Nov 8, 2024 |
| Nov 7, 2024 | SYK STRYKER CORP | MOption exercise Employee Stock Option granted 2/11/2015 (right to buy)derivative | -156,890 | $0.00 | $0 | 0 | Nov 8, 2024 |
| Oct 23, 2024 | PH Parker-Hannifin Corp | AGrant or award Restricted Stock Units | +299 | $0.00 | $0 | 11,077 | Oct 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.